News

Jan 17, 2024

Congress to PBMs: Reality Bites

If you think bipartisanship is hard, it’s even harder when it comes to healthcare. But there’s one thing nearly everyone agrees on –...

Dec 20, 2023

PBM Accountability Project Statement on Centers for Medicare & Medicaid Services Letter Warning Seniors About PBM Practices

The Centers for Medicare & Medicaid Services recently issued a letter to pharmacy benefit managers (PBMs), Medicare Part D Plans,...

Dec 13, 2023

Senator Chuck Grassley: Competition Is What's Needed to Break Drug Pricing Fever | Opinion

Decades of drug price inflation have reached a fever pitch that finally has lawmakers in both political parties itching for action. But,...

Dec 7, 2023

E&C approves PBM, Medicare coverage bills

The House Energy and Commerce Committee teed up a series of health bills for floor votes during a marathon markup on Wednesday afternoon....

Dec 1, 2023

Without Comprehensive PBM Reform, Patient Health Outcomes Will Suffer

As patients faced both high rates of inflation and record high costs at the pharmacy counter, President Biden signed the Inflation...

Nov 28, 2023

PBM Accountability Project and Nearly 50 Stakeholder Organizations Urge Congress to Pass PBM Reforms

Legislation will rein in the profiteering, anticompetitive and anti-consumer practices of PBMs, creating price transparency, making...

Nov 22, 2023

Expert: Working Together, Sharing Information Is Crucial to PBM Reform

In an interview with Pharmacy Times, Cheryl Larson, president and CEO of the Midwest Business Group on Health, discussed the employers’...

Nov 20, 2023

Health Insurers and PBMs Should Brace for a Copay Programs Shift

A federal court decision that struck down expanded use of copay accumulator programs should prompt health insurers and pharmacy benefit...

Nov 16, 2023

Eliminating Anticompetitive PBM Practices Are Free Market Reforms

The current drug pricing market is malfunctioning, an obvious conclusion to anyone who is paying attention. But why? Like much of the...

Nov 16, 2023

House panel passes PBM reforms, ratcheting up chance for passage

WASHINGTON — Panels in both the House and Senate have now passed restrictions to drug middlemen business practices, increasing the...

Nov 15, 2023

Physician entrepreneurs, policy reform can help small businesses navigate rising health care costs

As we approach the end of the year, businesses are facing a 10-year high health care cost hike. While ballooning prices affect all...

Nov 13, 2023

PBM Accountability Project Statement on Introduction of H.R. 6283

U.S. Representatives Mariannette Miller-Meeks (IA-01), Nanette Diaz Barragán (CA-44), Lori Chavez-DeRemer (OR-05), Kathy Manning (NC-06),...

Nov 9, 2023

Senate Finance Committee targets PBM reform in new legislation

In a unanimous 26-0 vote, the Senate Finance Committee passed a comprehensive draft package this week that puts pharmacy benefit manager...

Nov 8, 2023

Senate Finance unanimously advances PBM, mental health bill

The Senate Finance Committee today unanimously advanced a broad legislative package addressing mental health, PBMs and Medicare payment...

Nov 8, 2023

PBMs: When Competition Does Not Benefit Consumers

In recent years, the practices of pharmacy benefit managers (PBMs), initially formed to foster competition in the pharmaceutical market...

Oct 30, 2023

PBMs run media blitz calling out practices of their peers, telling policymakers reforms can cut cost

A group of pharmacy benefit managers (PBMs) has split off from the pack, launching a “six-figure digital media campaign” to make the case...

Oct 17, 2023

CMS' Proposed Drug Pricing Transparency Rule Impacting PBMs And Other PBM Updates

The United States Centers for Medicare & Medicaid Services ("CMS") has proposed new rulemaking (88 FR 34238) to increase drug price...

Oct 14, 2023

How the secrecy of middlemen inflates drug prices

Most Americans believe drugs cost too much and big pharma is to blame. That powerful political sentiment undergirds Medicare’s new...

Oct 3, 2023

Transparency Is The Cure For What Ails American Health Care

A government shutdown has been averted—for now. Congress approved a continuing resolution this weekend that funds the government through...

Oct 3, 2023

Court strikes down Trump-era rule that allowed health insurers to broadly use copay accumulators

A U.S. judge has struck down a Trump administration rule that allowed health insurers not to count copay assistance offered by drug...

Sep 30, 2023

PBM Accountability Project Statement on Senate Finance Committee PBM Legislation

The Modernizing and Ensuring PBM Accountability Act will bring transparency and accountability to PBM practices that drive up...

Sep 29, 2023

Bipartisan battle over prescription intermediaries heats up

The intermediaries in the prescription drug supply chain are stuck between a rock and a hard place, facing congressional scrutiny and...

Sep 20, 2023

Unravelling the Drug Pricing Blame Game

Prior to the COVID-19 pandemic, few healthcare issues received as much attention and public discourse as prescription drug prices. The...

Sep 19, 2023

PBMs, Big Pharma face off in House hearing

Pharmacy benefit managers emerged as public enemy No. 1 in a congressional hearing Tuesday, underscoring growing bipartisan sympathy for...

2 3

5 6